These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16158611)

  • 1. [Signal transduction abnormalities in systemic lupus erythematosus].
    Nagy G; Géher P; Koncz A; Perl A
    Orv Hetil; 2005 Jul; 146(31):1625-30. PubMed ID: 16158611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus.
    Perl A; Gergely P; Banki K
    Int Rev Immunol; 2004; 23(3-4):293-313. PubMed ID: 15204090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus.
    Vassilopoulos D; Kovacs B; Tsokos GC
    J Immunol; 1995 Aug; 155(4):2269-81. PubMed ID: 7636273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells.
    Nagy G; Barcza M; Gonchoroff N; Phillips PE; Perl A
    J Immunol; 2004 Sep; 173(6):3676-83. PubMed ID: 15356113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus.
    Nagy G; Perl A
    Clin Immunol; 2006; 118(2-3):145-51. PubMed ID: 16406340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Tsokos GC
    Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide, chronic inflammation and autoimmunity.
    Nagy G; Clark JM; Buzás EI; Gorman CL; Cope AP
    Immunol Lett; 2007 Jul; 111(1):1-5. PubMed ID: 17568690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation signal transduction by beta1 integrin in T cells from patients with systemic lupus erythematosus.
    Nakayamada S; Saito K; Nakano K; Tanaka Y
    Arthritis Rheum; 2007 May; 56(5):1559-68. PubMed ID: 17469136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling abnormalities in systemic lupus erythematosus as potential drug targets.
    Fernandez D; Bonilla E; Phillips P; Perl A
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):305-11. PubMed ID: 17214576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.
    Fujii Y; Fujii K; Tanaka Y
    Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus.
    Kucharz EJ; Sierakowski SJ; Goodwin JS
    Immunopharmacol Immunotoxicol; 1993 Nov; 15(5):515-23. PubMed ID: 8301016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal intracellular distribution of NFAT1 in T lymphocytes from patients with systemic lupus erythematosus and characteristic clinical features.
    Fujii Y; Fujii K; Iwata S; Suzuki K; Azuma T; Saito K; Tanaka Y
    Clin Immunol; 2006 Jun; 119(3):297-306. PubMed ID: 16503201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered T and B lymphocyte signaling pathways in lupus.
    Peng SL
    Autoimmun Rev; 2009 Jan; 8(3):179-83. PubMed ID: 18721908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered signal transduction in SLE T cells.
    Tenbrock K; Juang YT; Kyttaris VC; Tsokos GC
    Rheumatology (Oxford); 2007 Oct; 46(10):1525-30. PubMed ID: 17586862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy.
    Yoshimoto K; Takahashi Y; Ogasawara M; Setoyama Y; Suzuki K; Tsuzaka K; Abe T; Takeuchi T
    Int Immunol; 2006 Jul; 18(7):1189-96. PubMed ID: 16740602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus].
    Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmanial lipid suppresses tumor necrosis factor alpha, interleukin-1beta, and nitric oxide production by adherent synovial fluid mononuclear cells in rheumatoid arthritis patients and induces apoptosis through the mitochondrial-mediated pathway.
    Majumdar KN; Banerjee A; Ratha J; Mandal M; Sarkar RN; Saha KD
    Arthritis Rheum; 2008 Mar; 58(3):696-706. PubMed ID: 18311833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.